Profactor Pharma Ltd
ID: 6223314Operator of a biotechnology company intended to manufacture low-cost recombinant FVIII and transform the treatment of 'Haemophilia A'. The company offers innovative treatment by developing recombinant blood factors, enabling healthcare institutions to get access to an enhanced procedure to treat hemophilia.
1
Funding Rounds
$2.5m
Money raised
Recent Funding Rounds
Overview
- Website:
- Headquarters: Edinburgh
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Profactor Pharma Ltd has raised a total of $2.45m in funding over 1 rounds.
Key Insights:
- Profactor Pharma Ltd , September 2019: $2.45m